Health Care [ 4/12 ] | Biotechnology [ 18/72 ]
NASDAQ | Common Stock
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States.
It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics.
Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 2, 24 | -0.81 Decreased by -3.85% | -0.80 Decreased by -1.25% |
| Mar 5, 24 | -1.09 Decreased by -47.30% | -0.92 Decreased by -18.48% |
| Oct 30, 23 | -0.99 Decreased by -23.75% | -0.83 Decreased by -19.28% |
| Aug 3, 23 | -1.08 Decreased by -6.93% | -0.81 Decreased by -33.33% |
| May 11, 23 | -0.78 Decreased by -13.04% | -0.77 Decreased by -1.30% |
| Mar 2, 23 | -0.74 Increased by +26.00% | -0.84 Increased by +11.90% |
| Nov 3, 22 | -0.80 Increased by +3.61% | -0.92 Increased by +13.04% |
| Aug 4, 22 | -1.01 Decreased by -74.14% | -0.77 Decreased by -31.17% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | -60.21 M Decreased by -48.70% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -64.90 M Decreased by -25.17% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -42.50 M Decreased by -20.11% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -37.51 M Increased by +27.57% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -40.49 M Increased by +4.91% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -51.85 M Decreased by -73.10% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -35.38 M Decreased by -41.71% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -51.79 M Decreased by -80.76% | Decreased by N/A% Decreased by N/A% |